⌘K
t
Press release
28 April 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Investor presentation
Cellular Goods (LSE: CBX), a UK-based wellness company that provides premium consumer products formulated with lab-made cannabinoids, is pleased to announce that a new Investor Presentation has been uploaded to the Company's website, www.cellular-goods.com.
This presentation provides an overview of the Company's strategy and products and was used at an investor webinar hosted by PrimaryBid yesterday evening. No material new information was disclosed at the meeting.
For further information please contact:
|
Cellular Goods |
|
|
Anna Chokina Chief Executive Neil Thapar Investor Relations |
via Tancredi +44 207 887 7633
+44 787 645 5323 |
|
Tennyson Securities |
|
|
Corporate Broker Peter Krens |
+44 207 186 9030 |
|
Novum Securities |
|
|
Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
|
Tancredi Intelligent Communication |
|
|
Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs |
+44 744 922 6720 +44 791 503 5294 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
Generating summary...
| Date | 28 Apr 2022 |
| Time | 07:00:07 |
| Category | Miscellaneous |
| ID | 6104J |